P2.06-10 Combination Chemotherapy With Cisplatin, Pemetrexed, and Nivolumab for Malignant Pleural Mesothelioma: A Trial in Progress

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1265
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

P2.06-27 Extrapleural Pneumonectomy, Radiation Therapy, and Chemotherapy for Epithelioid Malignant Pleural Mesothelioma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Long Progression-Free Survival by Pemetrexed Continuation Maintenance Therapy Following Cisplatin-Based Chemotherapy in Malignant Pleural Mesothelioma

Internal Medicine
Internal MedicineMedicine
2014English

Adjuvant Bidirectional Chemotherapy With Intraperitoneal Pemetrexed Combined With Intravenous Cisplatin for Diffuse Malignant Peritoneal Mesothelioma

Gastroenterology Research and Practice
HepatologyGastroenterology
2012English

A Retrospective Study of Palliative Cisplatin-Based Doublet Chemotherapy for Malignant Pleural Mesothelioma

Cancer and Clinical Oncology
2014English

MA12.05 Phase 1 Study of HSP90 Inhibitor Ganetespib With Pemetrexed and Cisplatin/Carboplatin Chemotherapy for Pleural Mesothelioma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

In Vitro Characterization of Cisplatin and Pemetrexed Effects in Malignant Pleural Mesothelioma 3D Culture Phenotypes

Cancers
Cancer ResearchOncology
2019English

Chemotherapy of Malignant Pleural Mesothelioma.

Japanese Journal of Lung Cancer
OncologyRespiratory MedicinePulmonary
1990English

P2.06-15 Malignant Pleural Mesothelioma in Young Adult People in Uganda

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P1.09-011 LUME-Meso Phase II/III Study: Nintedanib + Pemetrexed/Cisplatin in Chemo-Naïve Patients With Malignant Pleural Mesothelioma

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy